In order to promote the academic prosperity of digestive diseases and the development of digestive disease diagnosis and treatment technologies in Yunnan Province, and to promote exchanges among digestive physicians inside and outside the province, the 2025 Digestion and Digestive Endoscopy Academic Conference was successfully held in Kunming, Yunnan from August 1 to 3, 2025, hosted by the Yunnan Medical Association, co-organized by the Gastroenterology Branch of the Yunnan Medical Association and the Digestive Endoscopy Branch of the Yunnan Medical Association, and co-organized by the Department of Gastroenterology of the First Affiliated Hospital of Kunming Medical University.
The conference focused on key areas of expertise and the application of cutting-edge technologies in health management. Numerous renowned experts in digestion and endoscopy were invited to participate in discussions through presentations and consensus-building sessions, aiming to jointly advance the discipline’s development.
As a high-level academic exchange platform for digestion and endoscopy in Yunnan Province, Eieling Technology showcased its liver health solution, Liverscan®, at the conference and engaged in in-depth discussions with participating experts.
Equipped with patented technology to achieve accurate assessment
As a leader in wireless ultrasound elastic imaging devices for chronic liver disease, Liverscan® attracted numerous experts and customers for consultation and experience at the event. Equipped with patented technology— the world’s exclusive patented technology for real-time B-mode ultrasound-guided transient elastography.
Liverscan® uses real-time image guidance to present liver tissue hardness and fat content with specific numerical values. Liverscan® can meet the testing needs of individuals with high BMI and abdominal obesity, quickly generating a patient’s liver health report. Furthermore, the liver hardness measurement ROI frame can be adjusted to effectively avoid non-liver parenchyma areas such as large blood vessels and cysts, enabling accurate liver assessment. With its real-time image positioning and convenient operation, Liverscan® significantly reduces medical costs and improves diagnosis and treatment efficiency, earning unanimous praise from experts.
As an innovative liver testing device, Liverscan® has been successfully implemented in numerous hospitals and has been highly recognized by clinicians. Liverscan® not only significantly improves the efficiency and accuracy of liver disease screening but also provides physicians with reliable diagnostic support, demonstrating its growing clinical value.
Leading a new era of liver health management with technological innovation
Guided by the “Healthy China 2030” strategic plan, Liverscan® will continue to leverage its technological advantages to drive innovation in liver health management. Going forward, we will continue to support the public with early liver screening, subsequent accurate diagnosis, and monitoring and follow-up, further reducing the morbidity and mortality of liver disease. At the same time, Liverscan® will maintain a global market presence and, through technological innovation, provide convenient, efficient, and reliable liver health solutions to users worldwide, bringing high-quality medical resources to a wider audience.